{"url_path":"/sec/ci/8-k/2026-04-27/item-5-07","section_key":"item-5-07","section_title":"Item 5.07 Submission of Matters to a Vote of Security Holders.","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-04-27","source_url":"https://www.sec.gov/Archives/edgar/data/1739940/0001140361-26-017123-index.html","accession_number":"0001140361-26-017123","cik":"0001739940","ticker":"CI","issuer_name":"Cigna Group","edgar_url":"https://www.sec.gov/Archives/edgar/data/1739940/0001140361-26-017123-index.html","primary_entity_key":"0001739940","primary_entity_name":"Cigna Group"},"word_count":358,"has_tables":true,"body_markdown":"Item 5.07\n\nSubmission of Matters to a Vote of Security Holders.\n\nThe Cigna Group held its Annual Meeting of Shareholders on April 22, 2026 (the “Annual Meeting”). Of the 263,660,761 shares outstanding and entitled to vote, 237,225,441\nshares, or 89.97%, were represented in person or by proxy at the Annual Meeting. The results for each of the proposals submitted to a vote of our shareholders at the Annual Meeting are set forth below. Each proposal is described in more detail in our\n2026 Proxy Statement, filed with the Securities and Exchange Commission on March 13, 2026.\n\nProposal 1: Shareholders elected the twelve director nominees named in the 2026\nProxy Statement for one-year terms to expire at the next annual meeting of shareholders.\n\nNominees\n\nVotes For\n\nVotes Against\n\nAbstentions\n\nBroker Non-Votes\n\nDavid M. Cordani\n\n213,026,538\n\n6,415,867\n\n178,426\n\n17,604,610\n\nBrian C. Evanko\n\n217,654,366\n\n1,786,597\n\n179,868\n\n17,604,610\n\nEric J. Foss\n\n207,618,924\n\n 11,810,097\n\n191,810\n\n17,604,610\n\nNeesha Hathi\n\n217,857,191\n\n 1,586,966\n\n176,674\n\n17,604,610\n\nMichael J. Hennigan\n\n218,927,778\n\n 505,709\n\n187,344\n\n17,604,610\n\nGeorge Kurian\n\n216,953,901\n\n 2,479,173\n\n187,757\n\n17,604,610\n\nKathleen M. Mazzarella\n\n217,741,575\n\n 1,713,851\n\n165,405\n\n17,604,610\n\nMark B. McClellan, M.D., Ph.D.\n\n218,991,478\n\n 443,519\n\n185,834\n\n17,604,610\n\nPhilip O. Ozuah, M.D., Ph.D.\n\n211,190,355\n\n 8,111,083\n\n319,393\n\n17,604,610\n\nKimberly A. Ross\n\n217,220,171\n\n 2,097,278\n\n303,382\n\n17,604,610\n\nEric C. Wiseman\n\n209,398,899\n\n 10,035,689\n\n186,243\n\n17,604,610\n\nDonna F. Zarcone\n\n211,230,853\n\n 8,221,767\n\n168,211\n\n17,604,610\n\nIn addition, shareholders voted on the following proposals and cast their votes as described below.\n\nProposal 2: Advisory approval of The Cigna Group’s executive compensation.\n\nVotes For\n\nVotes Against\n\nAbstentions\n\nBroker Non-Votes\n\n201,746,941\n\n17,359,954\n\n513,936\n\n17,604,610\n\nProposal 3: Ratification of the appointment of PricewaterhouseCoopers LLP as The\nCigna Group’s independent registered public accounting firm for 2026.\n\nVotes For\n\nVotes Against\n\nAbstentions\n\n216,061,458\n\n21,030,077\n\n133,906\n\nProposal 4: Shareholder Proposal – Shareholder right to act by written consent, if\nproperly presented.\n\nVotes For\n\nVotes Against\n\nAbstentions\n\nBroker Non-Votes\n\n104,982,574\n\n114,173,793\n\n464,464\n\n17,604,610\n\nSIGNATURE\n\n \n\nPursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly\nauthorized.\n\n \n\nTHE CIGNA GROUP\n\nDate: April 27, 2026\n\nBy:\n\n/s/ Andrea Nelson\n\nAndrea Nelson\n\nExecutive Vice President, General Counsel and Corporate Secretary"}